Global Fund - 2024 |
|
---|---|
State Department |
|
Programme |
|
Sub Programme |
|
Allocation: |
KES 22,520,960.00 (R) |
Key Performance Indicators
Key Output |
KPI |
Target Yr (2024) |
Target Yr (2025) |
Target Yr (2026) |
---|---|---|---|---|
Disease Control Services |
No. of patients receiving Anti- retroviral Therapy (ART) supplies (millions) |
1.3 |
1.3 |
1.3 |
Disease Control Services |
No. of people receiving Artemisinin Combination Therapy (ACT) (millions) |
7.0 |
8.0 |
8.0 |
Disease Control Services |
% of TB patients treated |
100 |
100 |
100 |
Previous Year Allocations
Num |
Year |
Recurrent |
Development |
Total |
---|---|---|---|---|
1 |
KES 22,520,960.00 |
KES 0.00 |
KES 22,520,960.00 |
|
2 |
KES 11,101,456.00 |
KES 0.00 |
KES 11,101,456.00 |
|
3 |
KES 6,099,626.00 |
KES 0.00 |
KES 6,099,626.00 |
|
4 |
KES 6,269,135.00 |
KES 0.00 |
KES 6,269,135.00 |
No. of PPP projects approved: 12
KES 86,537,104.00
KES 83,748,179.00
(2024)
Funds disbursed to MDAs as a % of the external resources mobilized: 100
KES 204,365,629.00
(2024)
% completion of construction: 100
KES 956,940,814.00
(2024)